Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood sugar control may determine UTI cure in diabetics

NCT ID NCT07188935

Knowledge-focused Sponsor: Al-Mustansiriyah University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 99 people with type 2 diabetes who had repeated urinary tract infections (UTIs). Researchers compared how well antibiotics worked in patients with good versus poor blood sugar control. They checked if the infection cleared after 14 days and if it returned within 30 days. The goal was to understand how diabetes management influences recovery from UTIs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ciprofloxacin 500 mg tablet
What this could lead to
If successful, this could help doctors personalize UTI treatment based on a patient's blood sugar control.
What could go wrong
This is a small, completed observational study, not a large trial. Results may not apply to all diabetes patients or different antibiotics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

99 people

The number who actually took part.

Started

Oct 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients age \>18 years, both sex * Patient with known history of T2DM at least 1 year * Patients diagnosed with rUTI according to the positive GUE as in practice guideline * Patients with different glycemic status according to the HbA1c level, and on different treatment for T2DM accordingly. * Patients with non-diabetic rUTI as active comparator. * Patients who had the ability to communicate to answer study questionnaire. Exclusion criteria: * Type 1 diabetic patients on insulin therapy were excluded. * T2DM Patients who were using Sodium-glucose co-transporter-2 inhibitors (SGLT-2) (because of their renal -related side effect). * Patients who received any antimicrobial treatment within the last 72 hours of their enrollment. * Women patients with recurrent vaginitis or urinary incontinence. * Men patients with BPH or over flow incontinence ( as a cause for r UTI). * Patients with chronic disease other than T2DM that may cause rUTI ( eg. CKD, Spinal cord injury. kidney stone). * Pregnancy and lactation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Recurrent urinary tract infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus urinary tract infections, recurrent, susceptibility to

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

T2DM (type 2 diabetes mellitus)

Contacts and locations

Locations

  • Al-Zahraa Teaching Hospital, Wasit, Iraq

    Kut, Wasit Governorate, 52001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.